Reversal of oxidative stress in endothelial cells by controlled release of adiponectin
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mossalam, Mohanad | - |
dc.contributor.author | Jeong, Ji-Hoon | - |
dc.contributor.author | Abel, E. Dale | - |
dc.contributor.author | Kim, Sung Wan | - |
dc.contributor.author | Kim, Yong-Hee | - |
dc.date.accessioned | 2022-12-21T01:35:15Z | - |
dc.date.available | 2022-12-21T01:35:15Z | - |
dc.date.created | 2022-08-26 | - |
dc.date.issued | 2008-09 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/178005 | - |
dc.description.abstract | Hyperglycemia causes endothelial dysfunction due to its effect on increasing reactive oxygen species (ROS). Adiponectin (Adp) has been reported to suppress hyperglycemia-associated ROS generation. It was hypothesized that administering globular adiponectin (gAdp) via injectable biodegradable thermosensitive triblock copolymer might effectively reduce ROS generation in endothelial cells. In this study, gAdp was incorporated into and released from the polymer gel. The released gAdp was further investigated by comparing it with the intact gAdp with regard to the efficiency in reducing ROS and activating cAMP. The released gAdp effectively suppressed excess ROS production in the in vitro endothelial cell culture model under high-glucose condition via cAMP/PKA pathway. These data provide a rationale for developing controlled release dosage form of gAdp as a therapeutic tool for oxidative stress-related pathology in patients with diabetes. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Reversal of oxidative stress in endothelial cells by controlled release of adiponectin | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Hee | - |
dc.identifier.doi | 10.1016/j.jconrel.2008.06.009 | - |
dc.identifier.scopusid | 2-s2.0-50949114724 | - |
dc.identifier.wosid | 000260269600006 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.130, no.3, pp.234 - 237 | - |
dc.relation.isPartOf | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 130 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 234 | - |
dc.citation.endPage | 237 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | DIABETIC COMPLICATIONS | - |
dc.subject.keywordPlus | TRIBLOCK COPOLYMERS | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | DELIVERY SYSTEMS | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | PATHOBIOLOGY | - |
dc.subject.keywordPlus | BLOCKS | - |
dc.subject.keywordAuthor | Controlled release | - |
dc.subject.keywordAuthor | Adiponectin | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.subject.keywordAuthor | Endothelial cells | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0168365908003398?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.